Multiple treatment comparison of seven new drugs for patients with advanced malignant melanoma: a systematic review and health economic decision model in a Norwegian setting

OBJECTIVE: To assess the relative effectiveness and cost-effectiveness of seven new drugs (cobimetinib, dabrafenib, ipilimumab, nivolumab, pembrolizumab, trametinib and vemurafenib) used for treatment of patients with advanced malignant melanoma in the Norwegian setting. DESIGN: A multiple technolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Pike, Eva, Hamidi, Vida, Saeterdal, Ingvil, Odgaard-Jensen, Jan, Klemp, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724191/
https://www.ncbi.nlm.nih.gov/pubmed/28827234
http://dx.doi.org/10.1136/bmjopen-2016-014880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724191/
https://www.ncbi.nlm.nih.gov/pubmed/28827234
http://dx.doi.org/10.1136/bmjopen-2016-014880

Ejemplares similares